Boehringer Ingelheim says it is on track to launch 25 new treatments in its human pharma division onto the market between now and 2030, fuelled by an R&D pipeline that it says is the best in its ...

Boehringer Ingelheim has a second positive trial under its belt for nerandomilast in pulmonary fibrosis, setting up regulatory filings. The new data from the 1,178-patient FIBRONEER-ILD study ...

Josh Johnson is WSFA's Chief Meteorologist, you can see his forecast every weeknight at 5, 6 and 10pm. Growing up in Jacksonville, Alabama, Josh has known he wanted to be a meteorologist in ...

Editors' Blog / Analysis & Opinion News Live Blog Morning Memo Cafe / outside voices & analysis Muckraker / scandal & investigations Prime / Member Exclusives Podcast Features Memberships View ...

"Republicans couldn’t have filled the seat without Justice Barrett. Mitch McConnell knew this, and for that reason insisted that she needed to be the nominee." ...

GLP-1s can deliver value to patients. But the fact that GLP-1s aren't cost-effective at their current net prices can limit insurer coverage and prevent equitable access. Gene Hackman’s death ...

After hours: March 21 at 4:38:46 PM EDT Loading Chart for WTW ...

This advertisement has not loaded yet, but your article continues below. The Prince Edward Island Regulatory and Appeals Commission (IRAC) announced a one-cent change to regular gas prices overnight, ...